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Illness in Long-Term Travelers Visiting GeoSentinel Clinics
Abstract
Length of travel appears to be associated with health risks. GeoSentinel Surveillance Network data for
4,039 long-term travelers (trip duration >6 months) seen after travel during June 1, 1996, through
December 31, 2008, were compared with data for 24,807 short-term travelers (trip duration <1 month).
Long-term travelers traveled more often than short-term travelers for volunteer activities (39.7% vs.
7.0%) and business (25.2% vs. 13.8%). More long-term travelers were men (57.2% vs. 50.1%) and
expatriates (54.0% vs. 8.9%); most had pretravel medical advice (70.3% vs. 48.9%). Per 1,000 travelers,
long-term travelers more often experienced chronic diarrhea, giardiasis, Plasmodium falciparum and P.
vivax malaria, irritable bowel syndrome (postinfectious), fatigue >1 month, eosinophilia, cutaneous
leishmaniasis, schistosomiasis, and Entamoeba histolytica diarrhea. Areas of concern for long-term
travelers were vector-borne diseases, contact-transmitted diseases, and psychological problems. Our
results can help prioritize screening for and diagnosis of illness in long-term travelers and provide
evidence-based pretravel advice.
Length of travel appears to be associated with health 
risks. GeoSentinel Surveillance Network data for 4,039 
long-term travelers (trip duration >6 months) seen after 
travel during June 1, 1996, through December 31, 2008, 
were compared with data for 24,807 short-term travel-
ers (trip duration <1 month). Long-term travelers traveled 
more often than short-term travelers for volunteer activities 
(39.7% vs. 7.0%) and business (25.2% vs. 13.8%). More 
long-term travelers were men (57.2% vs. 50.1%) and expa-
triates (54.0% vs. 8.9%); most had pretravel medical advice 
(70.3% vs. 48.9%). Per 1,000 travelers, long-term travel-
ers more often experienced chronic diarrhea, giardiasis, 
Plasmodium falciparum and P. vivax malaria, irritable bowel 
syndrome (postinfectious), fatigue >1 month, eosinophilia, 
cutaneous leishmaniasis, schistosomiasis, and Entamoeba 
histolytica diarrhea. Areas of concern for long-term travelers 
were vector-borne diseases, contact-transmitted diseases, 
and psychological problems. Our results can help prioritize 
screening for and diagnosis of illness in long-term travelers 
and provide evidence-based pretravel advice.
Travelers have many reasons for long durations of trav-el, including diplomatic work, education and research, 
missionary work, Peace Corps volunteer (PCV) work, mili-
tary operations, backpacking trips, and corporate expatriate 
assignments (1–7). Longer trips often are assumed to be 
associated with increased risk for some health problems, 
but few studies have compared the types and causes of ill-
ness in travelers on the basis of duration of travel. Previous 
studies suggested that long-term travelers are more likely 
than short-term travelers to acquire malaria (8) and that 
recommendations should be tailored individually (9). Other 
illness also might be more common in long-term than in 
short-term travelers.
To evaluate the effect of trip duration on illness, we 
compared illnesses by duration of travel for travelers seek-
ing treatment at GeoSentinel Surveillance Network sites. 
We also characterized long-term travelers’ demographics, 
travel patterns, and travel-related illnesses.
Methods
GeoSentinel Surveillance Network (www.istm.org/
geosentinel/main.html) sites are clinics on 6 continents that 
specialize in travel or tropical medicine and contribute data 
on travel-related illnesses and trip information. Our study 
comprised data from ill travelers visiting GeoSentinel sites 
from June 1, 1996, through December 31, 2008.
Inclusion Criteria
Persons in our study must have crossed an internation-
al border within the past 10 years and then sought treatment 
or medical advice at a GeoSentinel site for a presumed trav-
el-related illness. Only travelers with confi rmed and prob-
able diagnoses (including a healthy screening result) were 
included (Figure 1), and >1 diagnosis per patient was pos-
sible. Final diagnoses were assigned by a clinician.
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Data were collected according to a standardized, anon-
ymous questionnaire and entered into a Structured Query 
Language database. The questionnaire comprised demo-
graphic data (i.e., age, gender, country of birth, country of 
residence), travel history, inpatient or outpatient status, ma-
jor diagnoses, pretravel encounter for travel health advice, 
reason for most recent travel, patient classifi cation, and risk 
level qualifi er (e.g., prearranged or organized travel, risk 
travel, and expatriate status). Included in the analysis were 
persons traveling for tourism, visits to friends and relatives 
(VFR), business, military purposes, education, research, or 
missionary/volunteer work. We excluded records lacking 
an exposure destination or duration of travel, as well as re-
cords of immigrating travelers, travelers with multiple trips 
without a specifi ed location of exposure, fi nal diagnoses at-
tributed to travel of unspecifi ed duration, travel duration of 
1–6 months, and travelers seen during travel. We defi ned 
long-term travel as duration >6 months and short-term trav-
el as duration <1 month. Data for specifi c diagnoses and 
syndromes were analyzed for travelers seen after travel.
Diagnostic Categories
Final diagnoses were assigned a diagnostic code from 
a standardized list of ≈500 diagnoses, which were catego-
rized into 21 broad syndrome groups, as previously de-
scribed (10). Diagnosis codes with clear causal routes were 
analyzed by the following categories: ingestion, vector-
borne, contact (including respiratory, droplets, blood, body 
fl uid, sexual transmission), environment (water, soil, ani-
mal contact), psychosocial, and medication intolerance.
Statistical Analysis
Data were analyzed by using SAS software, version 
9 (SAS Institute, Cary, NC, USA). Proportionate illness 
was calculated as the number of patients with a specifi c or 
grouped diagnosis as a proportion of short-term or long-
term travelers, expressed per 1,000 persons in that category 
(10,11). Statistical signifi cance was determined by using χ2 
tests for categoric variables. For the most common diag-
noses in long-term travelers, odds ratios (ORs) with 95% 
confi dence intervals (CIs) were used to compare long-term 
with short-term travelers. A 2-sided signifi cance level of 
p<0.05 was chosen. To avoid a regional bias (i.e., some 
exposure regions differed signifi cantly between long-term 
and short-term travelers), we calculated ORs for the most 
common diagnoses in long-term travelers for the specifi c 
regions.
For long-term travelers, we performed multivariate lo-
gistic regressions to identify signifi cant factors associated 
with various diseases. We adjusted for age, sex, pretravel 
encounters, reason for travel, and geographic region vis-
ited. Signifi cant factors (p<0.05) were determined from 
stepwise selection.
Results
Demographics 
Of 41,168 eligible persons seen after travel, 24,807 
(60.3%) traveled for <1 month (short-term travelers), 
12,322 (29.9%) traveled for 1–6 months, and 4,039 (9.8%) 
traveled for >6 months (long-term travelers). Mean ages 
were 33 years for long-term travelers and 38 for short-term 
travelers (online Appendix Table 1, available from www.
cdc.gov/EID/content/15/11/1773-appT1.htm). The male:
female ratio was 4:3. Most long-term travelers (90%) were 
20–64 years of age, and most originated from countries in 
western Europe (43%) or North America (29%). Median 
duration for long-term travel was 365 days (mean 693 days, 
range 243–713 days) and for short-term travel was 14 days 
(mean 15 days, range 9–21 days).
Long-term travelers more often traveled for volunteer 
activities or research (40% vs. 7%) and business (25% vs. 
14%) and less often for tourism (29% vs. 70%). A larger 
proportion of long-term than short-term travelers were male 
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All GeoSentinel 
reports, 
N = 97,096 
Excluded: 
Travel for immigration, n = 15,208 
Not travel-related, n = 1,427 
Missing data, n = 36 
Travelers seen after and 
during international travel, 
n = 80,425 
No confirmed/probable final 
diagnosis, n = 2,525 
Trip duration unknown, n = 12,439 
Travelers seen after and during 
travel with known duration,  
n = 65,461 
Seen during travel, n = 24,293 
<1 mo, n = 11,600 
1–6 mo, n = 10,639 
>6 mo, n = 2,054 
Seen after travel, 
n = 41,168 
Short-term travelers 
(<1 month), n = 24,807 
Long-term travelers 
(>6 months), n = 4,039 
Travel duration 1–6 mo,  
n = 12,322 
Figure 1. Flow chart for analysis of illness and injury in long-term 
travelers, GeoSentinel Surveillance Network, June 1996–December 
2008.
Long-Term Travelers and GeoSentinel Clinics
(57% vs. 50%) and expatriates (54% vs. 9%), and most had 
sought pretravel medical advice (70% vs. 49%).
Long-term travelers more often traveled to sub-Saha-
ran Africa (34%) and South America (16%) than did short-
term travelers. Similar proportions of long- and short-term 
travelers went to south-central Asia (14% and 13%, re-
spectively), and the proportion of long-term travelers with 
exposure in Southeast Asia was lower than that of short-
term travelers. Intervals between return from travel to visit 
to a GeoSentinel site after long-term travel were <1 week 
(32%), 1–6 weeks (38%), and >6 weeks (30%).
Syndromes 
Predominant syndromes in long-term travelers seen af-
ter travel were febrile systemic illness, acute diarrheal syn-
drome, dermatologic problems, and other gastrointestinal 
problems (online Appendix Table 2, available from www.
cdc.gov/EID/content/15/11/1773-appT2.htm). A larger pro-
portion of long-term than short-term travelers were de-
termined to be healthy (196/1,000 travelers vs. 49/1,000 
travelers).
Most Common Diagnoses and Proportionate Illness 
Proportions of common diagnoses in long-term travel-
ers by world region visited are shown in Figure 2. Long-
term travelers were signifi cantly more likely than short-
term travelers to have chronic diarrhea (OR 1.20, 95% CI 
1.04–1.38); giardiasis (OR 1.57, 95% CI 1.32–1.86); P. 
falciparum malaria (OR 1.50, 95% CI 1.26–1.78); irritable 
bowel syndrome (postinfectious) (OR 1.69, 95% CI 1.41–
2.01), P. vivax malaria (OR 2.46, 95% CI 1.92–3.17); fa-
tigue >1 month (OR 3.09, 95% CI 2.86–4.01); eosinophilia 
(OR 3.34, 95% CI 2.53–4.42); cutaneous leishmaniasis (OR 
4.89, 95% CI 3.55–6.73); unspecifi ed schistosomiasis (OR 
4.45, 95% CI 3.16–6.25 [OR 4.26 for all schistosomiasis 
diagnoses together]); and Entamoeba histolytica diarrhea 
(OR 3.33, 95% CI 2.34–4.73) (Table 1). The most frequent 
regions of exposure for long-term versus short-term travel-
ers were sub-Saharan Africa (34.26% vs. 24.59%; OR 1.60, 
95% CI 1.48–1.73), followed by South America (16.38% 
vs. 7.30%; OR 2.49, 95% CI 2.24–2.76) and Southeast 
Asia (12.59% vs. 18.90%; OR 0.56, 95% CI 0.5–0.62, p = 
0.00000) (online Appendix Table 1). Diagnoses of acute in-
fections (such as dengue fever, rickettsiosis, acute diarrhea, 
acute bacterial diarrhea, infl uenza, and sexually transmitted 
infections), animal bites, and insect bites were signifi cantly 
more common in short-term travelers.
Comparison of Diagnoses by Causal Route 
Long-term travelers most commonly had diagnoses 
related to diseases with transmission by vectors or by in-
gestion. Larger proportions of long-term than short-term 
travelers had vector-borne diseases, contact-transmitted 
diseases (person-to-person, droplet, respiratory, sexually 
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Figure 2. Proportionate illness (per 1,000 ill travelers) for the most frequent diagnoses in long-term travelers, by world geographic region 
visited, GeoSentinel Surveillance Network, June 1996–December 2008. PEP, postexposure prophylaxis; IBS, irritable bowel syndrome; 
TB, tuberculosis; LTBI, latent TB infection; CLM, cutaneous larva migrans; P., Plasmodium.
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transmitted), and psychological problems (Table 2). Diag-
noses for long-term travelers varied for travel and region of 
exposure (online Appendix Table 2).
Discussion
Existing data are limited regarding the number and 
proportion of all long-term travelers. This analysis of the 
GeoSentinel Surveillance Network found that long-term 
travelers constituted 9.8% of all travelers visiting GeoSen-
tinel sites. In comparison, 5 travel medicine clinics in the 
Boston area found that ≈5% of travelers planned trips of ≥4 
months’ duration (12). More than 66% of long-term trav-
elers seen in the GeoSentinel Network had pretravel en-
counters, a higher percentage than shown in airport surveys 
of all travelers (range 31%–52% [13–15]). Many organi-
zations, such as missions, corporations, and aid agencies, 
require health screening of their employees or participants 
after long-term overseas service, which may have resulted 
in the high yield of healthy diagnoses (196/1,000 travelers). 
Particular areas to consider for pretravel counsel for long-
term travelers are vector-borne and contact-transmitted dis-
eases and psychological problems.
Ingestion Transmission
In our analysis, ingestion was the most common at-
tributable route of transmission for diseases in long-term 
travelers, although long-term travelers sought treatment 
less frequently than short-term travelers for ingestion-trans-
mitted diseases (OR 0.81, p<.0001). Enteric fever, acute 
diarrhea, chronic diarrhea, giardiasis, and other gastroin-
testinal parasites were reported signifi cantly more often in 
long-term than short-term travelers (p = 0.0024 for enteric 
fever, p<0.0001 for the rest). Young age was associated 
with giardiasis and other gastrointestinal parasites, possibly 
because of inexperience or more risk-taking behavior. Gi-
ardiasis occured more often in long-term travelers to sub-
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Table 1. Most common diagnoses for long-term travelers (n = 4,742) seen after travel and proportionate illness compared with short-
term travelers (n = 28,618), GeoSentinel Surveillance Network, June 1996–December 2008* 
Odds ratio (95% confidence interval) 
Rank† Diagnosis
Rate/1,000
travelers
Overall South
America
Southeast
Asia
Sub-Saharan 
Africa
All other 
regions
1 Diarrhea, chronic unknown 50 1.20‡
(1.04–1.38) 
1.19
(0.81–1.75) 
1.59§
(1.05–2.39) 
0.92
(0.64–1.31) 
1.19
(0.99–1.44) 
2 Giardia spp. 36 1.57‡
(1.32–1.86) 
0.85
(0.49–1.47) 
1.48
(0.80–2.73) 
1.93‡
(1.39–2.67) 
1.59‡
(1.26–2.01) 
3 Irritable bowel syndrome, 
postinfectious
36 1.69‡
(1.41–2.01) 
2.13§
(1.42–3.18) 
2.76§
(1.52–5.02) 
1.59¶
(1.03–2.45) 
1.42§
(1.11–1.80) 
4 Malaria, Plasmodium 
falciparum
36 1.50‡
(1.26–1.78) 
NA 5.05‡
(2.58–9.88) 
1.05
(0.86–1.27) 
2.77§
(1.58–4.87) 
6 Malaria, P. vivax 19 2.46‡
(1.92–3.17) 
0.83
(0.33–2.07) 
4.79‡
(2.86–8.01) 
1.14
(0.67–1.94) 
3.66‡
(2.57–5.22) 
8 Fatigue >1 month (not febrile) 18 3.09‡
(2.86–4.01) 
3.45§
(1.59–7.50) 
1.94
(0.86–4.37) 
1.79
(0.98–3.25) 
4.27‡
(3.01–6.05) 
9 Eosinophilia 17 3.34‡
(2.53–4.42) 
3.49§
(1.56–7.83) 
3.11§
(1.46–6.60) 
4.11‡
(2.46–6.84) 
2.89‡
(1.91–4.37) 
11 Leishmaniasis, cutaneous 14 4.89‡
(3.55–6.73) 
9.14‡
(5.15–16.24) 
NA 0.77
(0.09–6.40) 
2.30§
(1.35–3.92) 
12 Schistosomiasis, human 
species unknown# 
13 4.45‡
(3.16–6.25) 
2.92
(0.18–46.68) 
3.30
(0.34–31.80) 
3.10‡
(2.09–4.59) 
7.44‡
(3.83–14.47) 
17 TB, positive PPD or IGRA 11 3.26‡
(2.33–4.56) 
2.92
(0.73–11.72) 
24.27‡
(8.52–69.17) 
2.44¶
(1.13–5.26) 
2.68‡
(1.71–4.18) 
18 Entamoeba histolytica,
diarrhea
11 3.33‡
 (2.34–4.73) 
2.57
(0.93–7.10) 
1.52
(0.34–6.77) 
3.88‡
(1.95–7.72) 
3.52‡
(2.23–5.56) 
21 Stress 9 5.70‡
(3.77–8.61) 
NA 1.65
(0.20–13.73) 
7.57‡
(3.13–18.30) 
5.55‡
(3.32–9.30) 
22 Epstein-Barr virus 8 2.60‡
(1.72–3.91) 
12.86‡
(3.65–45.27) 
2.99¶
(1.20–7.48) 
0.38
(0.05–2.96) 
2.29§
(1.30–4.03) 
25 Strongyloidiasis, simple 
intestinal
7 1.85§
(1.24–2.75) 
0.83
(0.17–4.01) 
3.11¶
(1.14–8.53) 
1.62
(0.88–2.99) 
1.89
(0.94–3.81) 
*Long-term travel is defined as >6 mo, short-term travel as <1 mo. NA, not applicable; TB, tuberculosis; PPD, purified protein derivative test; IGRA, 
interferon-gamma release assay. 
†Among 25 most common illnesses for all travelers. 
‡p<0.0001. 
§p<0.01. 
¶p<0.05. 
#Aggregated schistosomiasis diagnoses (mansoni, haematobium, japonicum, mekongi, and unknown) are grouped together and shown in online 
Appendix Table 3, available from www.cdc.gov/EID/content/15/11/1773-appT.htm. 
Long-Term Travelers and GeoSentinel Clinics
Saharan Africa than in short-term travelers there (OR 1.93, 
p<.0001); that difference was not apparent for travelers to 
South America and Southeast Asia.
Epidemiologic surveillance of PCVs (1985–1987, 
>5,500 volunteers) found similar results: among the most 
common illnesses during service were diarrhea and giardia-
sis (16). More recently, the major health problems experi-
enced by PCVs in Madagascar were gastrointestinal, derma-
tologic, and respiratory (5). Examination during home leave 
of British missionaries who served in 27 countries found 
diarrhea and giardiasis to be the most common problems, 
and those who served in West Africa had more illnesses (7). 
Not surprisingly, children of missionaries encountered poor 
water treatment and food sanitation (2); before hepatitis A 
vaccine was available, a questionnaire of mission boards 
identifi ed viral hepatitis as the most serious health problem 
among missionaries (4). Among 328 North American mis-
sionaries evaluated during 1967–1984, 5.8% seroconverted 
to hepatitis A (this percentage may underestimate risk with-
out prophylaxis because they presumably had received im-
mune globulin); 0% seroconverted to hepatitis E after an 
average of 7.3 years of service (17). We found a higher risk 
for hepatitis A in long-term travelers, but the difference was 
not statistically signifi cant (OR 1.21, p = 0.5328). With the 
wide availability of hepatitis A vaccine today and the con-
sensus for its broad use for travel to developing regions, 
most travelers, especially those planning long-term travel, 
are expected to have been vaccinated.
A major vaccine-preventable disease is typhoid fe-
ver. Long-term travelers more frequently had enteric fever 
(typhoid and paratyphoid) than did short-term travelers 
(9/1,000 vs. 5/1,000 travelers; OR 1.70, p = 0.0024). A past 
estimate of the attack rate for typhoid in expatriates was 
3/100,000 travelers per month of stay (18). Enteric fever 
was signifi cantly associated with travel to south-central 
Asia, refl ecting the distribution of enteric fever; vaccina-
tion should particularly be emphasized to long-term trav-
elers, even though the effi cacy of currently available vac-
cines is only 60%–70%.
A survey of corporate expatriates found that food safe-
ty practices worsened as duration of stay increased (3). Ad-
herence to food and water precautions is diffi cult to main-
tain, as noted in a survey of 140 travelers in India whose 
median trip duration was 5 months (19). None had adhered 
fully to food and water precautions; 83% had diarrhea, and 
60% had diarrhea for ≈3% of their journey time.
Vector Transmission
Long-term travelers more frequently had vector-borne 
diseases than did short-term travelers because of the longer 
period during which bites can occur and possibly less vigi-
lance about personal protection measures and/or chemo-
prophylaxis during long stays. Long-term travelers also 
may have more primitive, remote, and rural living condi-
tions than short-term travelers. Leishmaniasis, malaria, and 
fi lariasis were all reported more frequently in long-term 
travelers than in short-term travelers (14, 68, and 5/1,000 
vs. 3, 39, and 2/1,000, respectively; p<0.0001). Regional 
variations were consistent with geographic disease distri-
bution (Table 1; online Appendix Table 3, available from 
www.cdc.gov/EID/content/15/11/1773-appT3.htm). Oth-
er associations of long-term travel and illness were male 
gender (leishmaniasis, malaria), VFR (malaria, fi lariasis), 
and missionary/volunteer/aid work/research (fi lariasis). 
Posttravel medical evaluation of 212 British missionaries 
indicated malaria as among the most common overseas 
illnesses (87.3/1,000 person-years at risk); more illnesses 
were associated with west Africa (688/1,000 person years 
at risk) than other regions (7). Among PCVs in Madagas-
car, 11 (15.9%) had malaria (8 cases/100 PCV-years) (5). 
Children of missionaries received suboptimal malaria pro-
phylaxis (2). Business travelers, despite understanding their 
risk for malaria, failed to use appropriate personal protec-
tion when duration of travel increased (20). Corporate ex-
patriates also adhered poorly to malaria chemoprophylaxis 
with longer stays in risk areas (3). Long-term travelers need 
better preparation for preventing, diagnosing, and treating 
malaria; novel approaches such as provision of rapid ma-
laria tests and adequate self-treatment medication should 
be considered for this high-risk population. Widespread 
proliferation of counterfeit drugs requires long-term travel-
ers to take adequate supplies with them (21,22).
Seroprevalence studies confi rm exposures to dengue 
virus in regions to which it is endemic: a serosurvey of 
323 development workers and family members had in-
creased seropositivity with longer stay (23). Seroconver-
sion occurred in 6.7% of 104 Israeli travelers with trips >3 
months’ duration in dengue-endemic countries and 2.9% of 
477 Dutch travelers to Asia (≈30/1,000 person-months of 
stay) (24,25). We found dengue was diagnosed less com-
monly in long-term travelers (OR 0.69, p = 0.0022) than in 
short-term travelers, perhaps because dengue has a short in-
cubation period and many infections occurring during pro-
longed stays are not confi rmed; diagnostic tests are usually 
not performed in countries endemic for dengue because of 
expense or lack of diagnostic capabilities.
Psychological Diagnoses
Some psychological diagnoses were reported sig-
nifi cantly more often in long-term travelers (OR 2.80, 
p<0.0001), particularly depression (OR 3.03, p<0.0001), 
nonmefl oquine psychosis (OR 3.89, p = 0.0006), stress 
(OR 5.70, p<0.0001), and fatigue (OR 3.09, p<0.0001); 
rates of anxiety, insomnia, substance abuse, and post-
traumatic stress disorder were equivalent to or lower than 
rates in short-term travelers. The increased number of 
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missionary/volunteer/research/aid workers with stress was 
most signifi cant (OR 32.18, (p<0.0001). Psychological 
rates were highest in eastern Europe and northern Africa 
and lowest in the Caribbean and Southeast Asia. Mission 
boards consider psychological conditions to be among the 
most common and serious conditions, specifi cally depres-
sion, stress, and burnout (4). Furthermore, psychiatric ill-
ness caused 60% of premature repatriations among British 
missionaries or their family members serving overseas (7). 
Nine (14%) of 66 fatalities among PCVs from 1984 to 2003 
were caused by mental illness (26).
In a survey of 1,340 long-term travelers from Israel 
(mean stay 5.3 months), 151 (11.3%) had neuropsychiatric 
problems during travel with a higher proportion of women 
(54.6%) and an association with mefl oquine use (27). Fur-
ther assessment found a mean stay abroad of 5.3 months. 
However, data on PCVs found that mefl oquine adverse 
events usually occurred early in prophylaxis (28).
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Table 2. Comparison of rates for diagnoses among long-term and short-term travelers seen after travel by causal routes and 
preventive measures, GeoSentinel Surveillance Network, June 1996–December 2008*† 
Rate/1,000 travelers 
Grouped diagnoses Short-term travelers Long-term travelers Odds ratio (95% CI) 
Vector-borne infections 76 109 1.47 (1.33–1.63) 
 Dengue 24 17 0.69 (0.551–0.88) 
 Chikungunya  2 2 1.16 (0.59–2.29) 
 Leishmaniasis 3 14 4.89 (3.55–6.73) 
 Malaria, all species  39 68 1.83 (1.61–2.08) 
 Rickettsiosis 8 2 0.22 (0.11–0.45) 
 Filariasis 2 5 3.22 (1.981–5.24) 
Ingestion 257 219 0.81 (0.75–0.87) 
 Enteric fever  5 9 1.70 (1.20–2.41) 
 Hepatitis A  2 3 1.21 (0.67–2.19) 
 Diarrhea, acute  123 41 0.31 (0.27–0.36) 
 Diarrhea, chronic  45 54 1.20 (1.04–1.38) 
 GI bacteria  34 15 0.42 (0.33–0.53) 
 Giardiasis  24 36 1.57 (1.32–1.86) 
 GI parasites  55 108 2.08 (1.88–2.312) 
Contact‡ 33 38 1.15 (0.70–1.90) 
 Influenza 8 5 0.60 (0.39–0.92) 
 Latent TB (positive PPD or IGRAs)  4 11 3.26 (2.33–4.56) 
 Acute mononucleosis syndrome (CMV, EBV, other) 7 11 1.60 (1.18–2.18) 
 Hepatitis B 2 2 0.67 (0.31–1.47) 
 Hepatitis C  1 2 1.73 (0.85–3.49) 
 Other sexually transmitted infections 7 4 0.67 (0.43–1.05) 
 HIV (acute infection) 2 1 0.39 (0.12–1.27) 
Environment 119 87 0.71 (0.63–0.79) 
 Schistosomiasis  6 24 4.26 (3.35–5.42) 
 Strongyloides  4 7 1.85 (1.24–2.75) 
 Hookworm  2 2 1.26 (0.62–2.60) 
 Animal bite   44 13 0.28 (0.22–0.37) 
 Other skin contact, noninfectious 60 18 0.29 (0.23–0.36) 
 Fungal infection (superficial/cutaneous mycosis) 4 10 2.33 (1.66–3.28) 
 Rash  19 19 0.98 (0.78–1.23) 
Psychological 15 40 2.80 (2.35–3.33) 
 Anxiety  3 4 1.60 (0.96–2.65) 
 Depression  2 6 3.03 (1.89–4.86) 
 Psychosis, nonmefloquine  1 2 3.89 (1.68–8.99) 
 Stress  2 9 5.70 (3.77–8.61) 
 Fatigue >1 mo 6 18 3.09 (2.86–4.01) 
Adverse events from medication or vaccine 7 3 0.44 (0.26–0.74) 
 Mefloquine intolerance  4 1 0.19 (0.07–0.52) 
 Medication intolerance, nonmefloquine  3 2 0.83 (0.44–1.56) 
*Long-term travel defined as >6 mo, short-term as <1 mo. CI, confidence interval; GI, gastrointestinal; TB, tuberculosis; PPD, purified protein derivative; 
IGRA, interferon-gamma release assay; CMV, cytomegalovirus; EBV, Epstein-Barr virus.  
†Diagnoses with proportionate illness <1/1,000 are omitted from table listing, such as hepatitis E, hepatitis delta, meningococcal meningitis, Haemophilus 
influenzae type b, pneumonia, pneumococcal pneumonia, varicella, chronic hepatitis, leptospirosis, altitude sickness, posttraumatic stress disorder, 
substance abuse, insomnia, delusional parasitosis, trauma, and violence exposure. Some patients may have >1 diagnosis. 
‡Includes respiratory illnesses, blood/body fluid exchange, and sexually transmitted infections. 
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Although our analysis identifi ed no substance abuse, 
an earlier study of 18–30-year-old travelers to the tropics 
found that approximately one third of survey responders 
used illicit drugs during their trip, especially travelers to 
the Far East. The strongest predictors of drug abuse were 
the combination of female sex and travel to Asia, education 
<12 school years, age <25 years, and lack of malaria pro-
phylaxis. Providing antidrug brochures did not affect the 
drug abuse rate (29).
Contact or Person-to-Person Transmission
Latent tuberculosis (positive purifi ed protein deriva-
tive [PPD] or interferon-gamma release assays) was di-
agnosed more commonly in long-term than in short-term 
travelers (11 vs. 4/1,000; OR 3.26, p<0.0001), whereas in-
fl uenza was diagnosed less commonly in long-term travel-
ers (5 vs. 8/1,000, OR 0.60, p = 0.0183). PCVs serving in 
Madagascar most commonly reported respiratory problems 
and gastrointestinal and skin conditions, including 5.8% 
with Mantoux of >5 mm induration (3 cases/100 volunteer-
years) (5). Peace Corps data from January 1, 1996, through 
December 31, 2005, showed rates of positive PPD conver-
sions and active TB cases to be 1.283 and 0.057 per 1,000 
volunteer-months, respectively; the African region had the 
highest PPD conversion rate, followed by the European re-
gion (30). Other studies on PPD conversion among travelers 
have reported rates up to 3.5/1,000 person-months (31).
Acute mononucleosis syndromes was signifi cantly 
higher in long-term than in short-term travelers (11 vs. 
7/1,000 travelers, OR 1.60, p = 0.0024) but no signifi cant 
difference for other diseases transmitted through sex or 
body fl uids. Younger age, male sex, lack of pretravel ad-
vice, and exposure in western Europe were associated with 
diagnoses of acute mononucleosis syndromes.
Among PCVs in Madagascar, the reported incidence 
of sexually transmitted infections was 6.9% (5.6% of fe-
males and 13.3% of males); 8.7% of those volunteers need-
ed postexposure prophylaxis for human immunodefi ciency 
virus (5). Long-term missionaries in developing countries 
had seroconversion rates of 5.5% to antibody to hepatitis 
B core antigen and 0.6% to antibody to hepatitis C virus, 
suggesting signifi cant exposure to hepatitis B (17). In our 
study, hepatitis B infection was diagnosed more often in 
short-term than long-term travelers, although not signifi -
cantly so (OR 0.67, p = 0.3131). More potential exposures 
to hepatitis B is expected during long-term travel; there-
fore, hepatitis B vaccine is routinely recommended for 
long-term travelers. (32). A plausible explanation for our 
result is that a high percentage of long-term travelers had 
been vaccinated against hepatitis B. Hepatitis B infection, a 
vaccine-preventable disease, should be targeted for preven-
tion in travelers.
Environmental Cause
Among diagnoses attributed to soil and water expo-
sure, schistosomiasis and strongyloidiasis were more com-
mon in long-term travelers (24 and 7/1,000 travelers; OR 
4.26, p<0.0001, and 1.85, p = 0.0021, respectively) and 
were associated with males. Schistosomiasis was also asso-
ciated with tourism and missionary/volunteer/research/aid 
work, and strongyloidiasis was associated with VFR. An 
earlier study found that 8 (11.6%) of 69 PCVs who served 
in Madagascar had antischistosomal antibodies (5).
Although ectoparasites (scabies, sand fl ea, and head 
lice) were reported in 11.6% of PCVs (5), long-term travel-
ers in our study, compared with short-term travelers, had a 
proportionately lower number of other skin conditions with 
possible environmental exposures (OR 0.29, p<0.0001) but 
a proportionately higher number of fungal skin infections 
(OR 2.33, p<0.0001).
Rabies risk has been considered to increase with longer 
duration of travel, and preexposure prophylaxis is typically 
recommended, particularly for long stays. Our data showed 
a lower proportionate need for postexposure prophylaxis 
(not actual rabies) in long-term travelers than in short-term 
travelers (7 vs. 23/1,000, OR 0.31, p<0.0001), possibly be-
cause long-term travelers may be more knowledgeable or 
better educated about animal exposure risks, more likely to 
avoid exposures, and more likely to have been vaccinated 
before travel. In PCVs, potential exposure to rabies was 10× 
higher abroad than domestically (1). Among Norwegian 
missionaries serving in developing countries for 4–5 years, 
7% had possible rabies exposure (33). A study of travelers 
returning from travel >1 month identifi ed 1.6% injured by a 
potentially rabid animal (mainly dog and monkey), or 2.66 
per 1,000 travelers per month (34). Those injured had sig-
nifi cantly longer trips (mean 6.9 mo, ±3.8 SD); only 31% 
sought appropriate medical treatment (34).
Injury
Mission boards consider injury among the most com-
mon and serious conditions (4,35). The leading cause of 
death in Africa for American missionaries during 1970–
1985 was motor vehicle injury (35). Of 66 deaths occurring 
in PCVs from 1984 to 2003, injury was the primary cause 
(45), including motor vehicle injuries, most commonly by 
automobile but also by bus, truck, taxi, minibus taxi, and 
motorcycle (26). Among 1,190 returned expatriates, most 
of whom had served the International Committee of the 
Red Cross for >6 months, 10% reported injury or accident 
during their service (36). Injured travelers are unlikely to 
seek care at a GeoSentinel site, so our analysis has limited 
data about injury.
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Limitations
Our fi ndings are subject to several limitations. The Ge-
oSentinel database captures travelers who sought treatment 
at specialized travel and tropical medicine clinics and who 
may not be representative of all travelers. Long-term trav-
elers may be more likely than short-term travelers to seek a 
GeoSentinel site because of concern about unusual tropical 
diseases. We used only GeoSentinel data, so proportionate 
frequency of diagnoses for long-term travelers compared 
with short-term travelers in this database can be derived, 
but not risk for illness. Missing travel duration eliminated 
≈10% of records from analysis. Paucity of injury data is 
another limitation of the analysis because injury is a major 
cause of illness and death in long-term travelers. Similarly, 
travelers with dental, ophthalmologic, obstetric, and gyne-
cologic problems rarely visit GeoSentinel sites.
Conclusions
Approximately 10% of all ill travelers seen at Geo-
Sentinel sites are long-term travelers. Long-term travelers 
are characterized by male gender and travel for missionary/
volunteer/research or business; most had pretravel evalua-
tions. Among the problems more frequently seen in long-
term travelers than in short-term travelers are infections 
with long incubation and long-lasting or chronic durations; 
malaria is especially important, as are leishmaniasis, fi lari-
asis, gastrointestinal parasites, schistosomiasis, and latent 
tuberculosis. Many vector-borne diseases with short incu-
bation periods (e.g., dengue, chikungunya, rickettsia) are 
diagnosed more often in short-term travelers. These fi nd-
ings do not mean that these infections occur less often in 
long-term travelers, only that they are not active when 
long-term travelers are seen after travel; a similar situa-
tion may be true for animal bites. Many common infections 
seen in long-term travelers are preventable by vaccines, 
vector avoidance, food/water precautions, and avoidance 
of soil and fresh water. Psychological problems, especially 
depression, stress, nonmefl oquine psychosis, and pro-
longed fatigue, increase with long-term travel. The high 
OR (32.18) of missionary/volunteer/research/aid workers 
with stress merits attention and intervention. Clinicians 
must be alert to psychological problems and manage them, 
as reentry and readjustment for long-term travelers may be 
diffi cult. Among the vaccine-preventable diseases, enteric 
fever and hepatitis A increase with long-term travel. Be-
cause >50% of ailments for which long-term travelers visit 
a healthcare provider are preventable and 70% of long-term 
travelers had pretravel visits, opportunities exist to educate, 
vaccinate, provide malaria chemoprophylaxis, and prepare 
these travelers for possible break-through infection.
Disease patterns differed signifi cantly for long-term 
and short-term travelers. Particular areas of concern for 
long-term travelers are vector-borne, ingestion-transmitted, 
contact-transmitted disease, and psychological problems. 
Our results can help identify priorities for screening and 
diagnosing illnesses in long-term travelers and for provid-
ing evidence-based pretravel advice.  
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